

"Pan-European pharmaceutical market access consultancy navigating regulatory and payer pathways"
Kintiga specialises in pharmaceutical market access, regulatory affairs, and health technology assessment across Europe. The company guides biotech and pharmaceutical developers from clinical development to patient access, helping secure regulatory approval, demonstrate value to payers, and navigate reimbursement. With offices in the UK, Germany, and Belgium, Kintiga combines local expertise with pan-European strategy. The team delivers strategic advisory, EU HTA procedures, pricing strategy, health economics modelling, and stakeholder engagement. Kintiga offers AI tools for dossier creation. These capabilities matter for companies seeking efficient routes that maximise patient access while meeting regulatory and payer requirements.


85
Team Members
2024
Founded
Consulting
Sector
Hybrid
Work Environment
A Europe where every health technology reaches its full potential, ensuring patients gain timely access to life-changing treatments through streamlined regulatory and payer pathways that recognise true clinical value.
At Kintiga, our mission is to partner with health technology developers to elevate their capabilities and expand European patient access through expert guidance, innovative tools, and impeccable delivery.